Advertisement

Topics

Kahn Swick & Foti, LLC Company Profile

16:38 EST 18th November 2017 | BioPortfolio

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action litigation with offices in New York and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders. Recent cases include In re Virgin Mobile USA IPO Litigation, 2:07-cv-05619-SDW-MCA (D. N.J.), Co-Lead Counsel, $19.5 Million Settlement Preliminarily Approved; In re BigBand Networks, Inc Securities Litigation, 3:07-CV-05101-SBA (C.D. Cal.), Co-Lead Counsel, $11 million settlement; In re U.S. Auto Parts Networks, Inc. Securities Litigation, 2:07-cv-02030-GW-JC (C.D. Cal.),Lead Counsel, $10 million settlement. KSF is also federally court-appointed Co-Lead Counsel in THE shareholder derivative cases against AIG and Bank of America (Merrill Lynch merger) emanating from their recent multi-billion dollar economic declines.


News Articles [25 Associated News Articles listed on BioPortfolio]

DIMENSION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dimension Therapeutics, Inc.

NEW ORLEANS, Aug. 28, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sa...

INTELLIPHARMACEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Lawsuit Against IntelliPharmaCeutics International, Inc. - (IPCI)

NEW ORLEANS, LA--(Marketwired - August 04, 2017) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

Allergan Shareholder Alert by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)

NEW ORLEANS, LA--(Marketwired - August 01, 2017) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

SINOVAC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick Foti, LLC ...

NEW ORLEANS, June 27, 2017/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Read more...

TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited (T

NEW ORLEANS, LA--(Marketwired - September 01, 2017) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they hav...

PetMED INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates PetMed Express, Inc. for Possible Securities Fraud - (PETS)

NEW ORLEANS, Aug. 25, 2017 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has com...

DR. REDDY’S 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney ...

Kahn Swick & Foti, LLCLewis Kahn, Managing Partner, 877-515-1850lewis.kahn@ksfcounsel.com Read more...

DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)

NEW ORLEANS, Sept. 15, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unt...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Dipentum [Alaven Pharmaceutical LLC]

Dipentum (olsalazine sodium capsules)

Dipentum (olsalazine sodium capsules) [UCB, Inc.]

DIPENTUM (olsalazine sodium capsules)

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Carrying Skills From One C-Suite to Another: An Interview With Dr Maureen Swick.

This interview of Dr Maureen Swick chronicles career development and preparation for a transition into the role of CEO of the American Organization of Nurse Executives. While there are an estimated 40...

Identifying Stable Variants of Callous-Unemotional Traits: A Longitudinal Study of At-Risk Girls.

Callous-unemotional (CU) traits have proven important for designating children and adolescents showing a pattern of particularly severe, stable, and aggressive antisocial behaviors (Frick, Ray, Thornt...

White Paper: Interventional MRI: Current Status and Potential for Development Considering Economic Perspectives, Part 2: Liver and Other Applications in Oncology.

Background MRI is attractive for guiding and monitoring interventional procedures due to its high intrinsic soft tissue contrast and the possibility to measure flow and cardiac function. Methods T...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

This study intends to compare novel antipsychotics ziprasidone and olanzapine, to confirm the findings of an open study -where stable patients receiving olanzapine switched to ziprasidone-...

Companies [2 Associated Companies listed on BioPortfolio]

Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action litigation with offices in New York and Lo...

Attorney Robert A. Kahn

More Information about "Kahn Swick & Foti, LLC" on BioPortfolio

We have published hundreds of Kahn Swick & Foti, LLC news stories on BioPortfolio along with dozens of Kahn Swick & Foti, LLC Clinical Trials and PubMed Articles about Kahn Swick & Foti, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kahn Swick & Foti, LLC Companies in our database. You can also find out about relevant Kahn Swick & Foti, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record